🆕 BREAKING – New
@WHO
guidance – People living with
#HIV
who achieve an undetectable viral load who are on consistent ART can not pass HIV on to their sexual partner(s) & are at low risk of transmitting HIV vertically to their children.
#UequalsU
#IAS2023
For people living with
#HIV
, this is the biggest news coming out of this conference. Millions of people around the world living with HIV can now say ‘We have zero risk of transmitting HIV when we are on medication and suppressed.’ -
@PreventionAC
's Micheal Ighodaro 🇺🇸
#IAS2023
The final results are in. After eight years, the landmark PARTNER study has found zero risk of
#HIV
transmission between sexual partners with suppressed HIV viral loads
#UequalsU
"Thanks to scientific inquiry, a positive
#HIV
test no longer means a death sentence. A mother living with HIV can give birth without passing it on to her child, and an undetectable viral load is untransmittable between partners." – IAS President
@ProfAdeeba
opening
#IAS2021
🎥 A protest at
#IAS2023
celebrating
@WHO
’s brief encouraging health professionals to say there’s ZERO risk when HIV is undetectable
#UequalsU
.
At IAS, we welcome protests because progress happens when science, policy and activism come together.
#SayZero
Our new
#HIV
and
#coronavirus
(COVID-19) information portal is now live, featuring the latest COVID-19 information and advice for people living with HIV, as well as ways to get involved
#Australia
may become world’s first nation to end the
#HIV
epidemic & reach the
@UN
target to end
#AIDS
as a public health threat by 2030.
Check out all the breaking news & groundbreaking research from today's
#IAS2023
Australian-focused press conference!
Exciting news in
#HIV
prevention: twice-a-year injections of
#lenacapavir
completely protected cisgender women from acquiring HIV in a large study conducted in Africa.
Promising news:
#Amsterdam
's
#HIV
cases have dropped by 95% since 2010, to just 9 new cases in 2022! This achievement is attributed to making PrEP widely accessible and effective community responses.
Find out + about this development on
@Aidsfonds_intl
:
In an exciting development, a new clinical trial just administered the first doses of an
#HIV
#mRNA
vaccine!
Read more about this innovative partnership between
@moderna_tx
and
@IAVI
! via
@abcnews
🆕 BREAKING –
@QldGov
's
@ShannonFentiman
announces that
#Queensland
, Australia, will remove co-payment for antiretroviral therapy, making these already-subsidized medicines for people living with
#HIV
absolutely free.
#IAS2023
The IAS mourns the passing of two world-leading
#HIV
scientists, David Katzenstein, Professor of Medicine at Stanford University, and James Hakim, Professor of Medicine at the University of Zimbabwe College of Health Sciences, who died from COVID-19 related complications.
A huge welcome to all the
#IAS2023
scholarship recipients joining us both in
#Brisbane
and virtually! 🎓
#IAS2023
welcomes 330 scholarship recipients from 63 countries.
"People living with
#HIV
who have an undetectable viral load have ZERO risk of transmitting HIV to their sexual partners." -
@WHO
's Lara Vojnov 🇺🇳
#IAS2023
#SayZERO
👏
Announcing the COVID-19 Conference - a free virtual conference exploring breaking
#COVID19
research, policy analysis and frontline experience. Register or submit an abstract to the world’s first abstract-led conference on COVID-19
#COVIDconf
It is with a profoundly heavy heart that the IAS bids farewell to Timothy Ray Brown, the first person to be cured of
#HIV
. Known as the “Berlin Patient”, Timothy was cured in 2008 after undergoing a complex stem cell transplant for lymphoma. Our statement:
📣
@WHO
has put out a clear message at
#IAS2023
that people living with
#HIV
can have “zero risk” of transmitting
#HIV
if they adhere to prescribed HIV treatment.
✅ Find out more about this major update & spread the word using
#SayZero
on social media!
BREAKING:
@WHO
report to be presented at
#IAS2021
concludes that
#HIV
infection is a significant independent risk factor for both severe
#COVID19
illness at hospital admission and in-hospital mortality.
‘’Although the
#AIDS
epidemic taught us that misinformation is lethal, it also showed us how powerful the medical and research communities can be when they work together, speak up, and demand attention and action.’’ –
#IAS2021
Scientific Chair
@hendrikstreeck
at
#WHS2020
Missed
#IAS2023
? Get caught up on the groundbreaking
#HIV
science shared at the world's most influential meeting on HIV research!
✴️ Check out 8 key takeaways:
📸 View photo highlights:
📽️ Watch videos:
“As we journey on, we have to push for a vaccine and a cure. And while we do this, we also need other cures. A cure for stigma, a cure for discrimination, a cure for violence and a cure for inequality.” New IAS President Anton Pozniak.
#AIDS2018
"Personal drug use should be viewed as a health and social issue, and not a criminal justice issue. There is an excessive incarceration of people who use drugs leading to many negative health consequences including
#COVID19
" - IAS President
@ProfAdeeba
#HLM2021AIDS
Researchers at
@UW
developed a long-acting injectable form of the widely used
#HIV
antiretroviral combination TLD (tenofovir disoproxil fumarate, lamivudine & dolutegravir). This innovation could improve adherence to HIV treatment.
Read more in
@aidsmap
:
📣
@WHO
shared a new message at
#IAS2023
that people living with
#HIV
have “zero risk” of transmitting HIV if they adhere to prescribed treatment.
🌐 Find out more about this major update and help spread the word by using
#SayZero
on social media!
Youth Hub Seed Grant applications are open!
We're pleased to invite young people to submit a proposal requesting up to USD 10,000 to implement a 6-month innovation project that addresses a need for young people living with & affected by
#HIV
.
Apply at
❓ Did you know? A person living with
#HIV
, on treatment, with an undetectable viral load for > 6 months has ZERO risk of passing on
#HIV
during sex.
Undetectable = untransmittable
#UequalsU
#SayZero
👀 Check out
@NAM
's new illustrated guide below!
Thank you to Adam Castillejo 🇬🇧, Paul Edmonds 🇺🇸, and Marc Franke 🇩🇪 for sharing their personal
#HIV
cure stories and inspiring us all to continue working towards a globally accessible HIV cure. 🙏
#AIDS2024
🌍 We're thrilled to welcome 864 scholarship recipients from 101 countries to
#AIDS2024
! 742 are joining us in
#Munich
. They represent:
💼 51 occupations
🏢 675 organizations
👤 Ages between 19-76
👥 70% first-time recipients
👏 We hope the conference is engaging & impactful!
1/7:
#IAS2025
will take place in
@CityofKigali
,
#Rwanda
, from 14 to 17 July 2025, with pre-meetings on 13 July!
It will spotlight challenges & opportunities in some of the world’s most
#HIV
-affected regions while offering insights from other areas. 🧵
We're loving
#Brisbane
's Story and Victoria bridges lit up red tonight🌉Thank you
@BCEC_Brisbane
&
@brisbanecityqld
for this show of solidarity with people living with and affected by
#HIV
. What a sight!
VIR-1388, an
#HIV
vaccine candidate, has begun Phase 1 clinical trial enrollment in the US & South Africa.
It aims to "instruct the immune system to produce T cells that can recognize HIV & signal an immune response to prevent chronic infection".
We are excited to announce that
#Montreal
, Canada will host
#AIDS2022
– the 24th International
@AIDS_Conference
! The hybrid conference will take place in-person and virtually from 29 July – 2 August 2022. Save the date and visit for the full announcement.
The US Food and Drug Administration has approved the first monthly injectable drug regimen to treat
#HIV
. Called Cabenuva, the treatment can replace current antiretroviral regimens in those who are virologically suppressed
1/4: Breaking news!
"This third case of an
#HIV
cure post bone marrow transplant from a donor naturally resistant to HIV, and the first in a women living with HIV, is a very exciting finding..."
-IAS President-Elect,
@ProfSharonLewin
via
@nytimes
"The 90-90-90 targets are actually 90-81-73 - this is not my mobile number" and the 10-10-10 is not Tintin but the populations that are being left behind".
#AIDS2018
plenary
@LSHTM
Director Peter Piot
“My name is Elizabeth Oyungo from Kenya. I call on everyone to decriminalise sex work now. Decriminalisation of sex work doesn’t stop sex work from happening. Criminalisation of sex work exposes us to harm, risks and exclusion.” - Protesters at
#IAS2023
#DecrimQLD
#SexWorkisWork
We're excited to announce Kevin Osborne as the next Executive Director of the International AIDS Society! Kevin has over 30 years of public health experience working with the
#HIV
community, and is the first IAS Exec Director openly living with
#HIV
The European Commission (EC) has approved lenacapavir, a "twice-yearly antiretroviral...for treatment-experienced people w/ multidrug-resistant
#HIV
".
Research on this drug was shared at
#IAS2021
& the EC becomes 1st regulatory agency to approve its use.
📣 Shout
#SayZero
from the rooftops! 🌆
👥 People living with
#HIV
who have an undetectable viral load and continue taking medication as prescribed have “zero risk” of transmitting HIV to their sexual partner(s)!
‘’I call on governments to foster scientific team work & to learn the many lessons from AIDS. A pandemic will not end in one country or one continent, nor by one institution or one researcher. It needs a global team.’’ –
#IAS2021
Local Scientific Chair
@hendrikstreeck
at
#WHS2020
“We need to keep
#HumanRights
central.
#HIV
has taught us, and COVID-19 and mpox have reminded us, that heath is not a luxury for those who can afford it.” – WHO’s
@DrTedros
#IAS2023
Ageing with
#HIV
: Prioritizing person-centred care. University of Malaya’s
@ReenaRajasuriar
🇲🇾 discussing the importance of person-centred care for people ageing with
#HIV
, at the IAS General Members’ Meeting.
#IAS2023
Pre-exposure prophylaxis (
#PrEP
) is safe and effective for widespread use, and could be given to millions of people worldwide with no increased risk of safety issues during treatment. New research from
#HIVGlasgow
today reaffirms the safety of PrEP
It’s a wrap! We were delighted for all those who were able to join us at
#IAS2023
.
Thank you for all your contributions towards forging a more equitable & innovative
#HIV
response!
Read the final Daily Digest to catch up on all of IAS 2023’s highlights!
A new study shows young people in South Africa, Uganda & Zimbabwe prefer on-demand
#PrEP
over daily PrEP largely because it reduces
#HIV
stigma. Understanding what young people think is essential for designing treatments that work for them.
More info 👇
Your words have power. Choose them with care.
✅"People living with HIV"
and not ❌"Infected" people
✅"HIV acquisition"
❌"Infection"
✅"A person who has acquired HIV"
❌"catching" or "spreading HIV"
Check out our website:
#HIVLanguageMatters
#HIV
"Leaders need to understand that the right to health is not negotiable and should not need to compete with other funding priorities." -
#IAS2019
International Scientific Chair
@AntonPozniak
at the official Opening Ceremony. Watch live here
1/3 - Nine years ago today, six leaders in the HIV response lost their lives on their way to the 20th International AIDS Conference in Melbourne on Malaysia Airlines flight
#MH17
.🧵
"We are focusing far too little on
#HIV
prevention. We have a broad prevention toolbox but it is not available to everyone… Where is the upfront investment in HIV prevention methods, in vaccines?" -
#IAS2021
Co-Chair
@hendrikstreeck
speaking at the
#WorldHealthSummit
Congratulations to our Immediate Past President
@LindaGailBekker
for receiving the 2018 Desmond Tutu Award for HIV Prevention Research and Human Rights in recognition of her leadership in research studies aimed at developing new
#HIV
prevention methods. 👏👏
#HIVR4P2018
In a growing number of African countries, women will soon have access to vaginal rings to help reduce their vulnerability to
#HIV
acquisition, thanks to
@Pop_Council
non-profit.
Read more in
@NPR
:
🔬 Two recent studies found that despite antiretroviral therapy effectively suppressing active
#HIV
, some cells continue to produce viral fragments that weaken the immune system.
Find out more in
@ScienceNews
:
📊 Today at
#AIDS2024
, Past IAS President
@LindaGailBekker
presents full results from PURPOSE 1 trial. The results confirm
#lenacapavir
demonstrated 100% efficacy for
#HIV
prevention in cisgender women.
Read IAS President & AIDS 2024 Int'l Co-Chair
@ProfSharonLewin
's statement.
"We've had an effective HPV vaccine for more than a decade, and yet only 55% of countries have an HPV vaccination programme." - IAS Immediate Past President
@ProfAdeeba
#IAS2023
“These data confirm that twice-yearly
#lenacapavir
for HIV prevention is a breakthrough advance with huge public health potential" - IAS President
@ProfSharonLewin
In a proof of concept,
@UvA_Amsterdam
"scientists say they have successfully eliminated
#HIV
from infected cells, using Nobel Prize-winning Crispr gene-editing technology".
▶️ Injectable
#HIV
PrEP is still not available in many countries, but about 80% of women in seven African countries prefer long-acting injectable PrEP to a daily pill, a large study showed, underlining the need to increasing access.
#IAS2023
#HPTN084
Save the date!
#AIDS2024
will take place in
#Munich
, Germany, & virtually from 22 to 26 July 2024. The conference will provide a platform to align around a unified & equitable response to the pandemic.
Sign up to receive the latest AIDS 2024 updates! 👇
#HIV
medication dolutegravir has been found to be superior to efavirenz in most outcomes, including viral suppression, tolerability and safety for people living with HIV, according to new research funded by
@WHO
We're providing scholarships for
#AIDS2024
to help with:
✔️ Registration
✈️ Travel
🛌 Accommodation
🍽️ Living expenses
🌐 Accessibility
Apply today for a virtual or in-person scholarship to attend the 25th International AIDS Conference! 👉
"I think we can all agree that there are several reasons why we might not take the pills we need to take every day... Lets avoid pill fatigue, people are fed up of taking pills everyday." -
@uchile
’s Claudia Cortes 🇨🇱
#IAS2023
People living with
#HIV
in many places around the world are at risk of criminalization because of their status. Check out our
#HIVunmuted
podcast episode on the impact of these unjust laws & what must be done to end HIV criminalization.
🎧 Listen now!
The Anti-Homosexuality Act is a grave setback for the HIV-response in Uganda. The science is clear: Criminalizing already marginalized groups has negative public health impacts for the targeted groups & for society at large. The IAS stands in solidarity with the LGBTQ community.
The Anti-Homosexuality Act 2023 will obstruct health education and the outreach that can help
#endAIDS
as a public health threat. Together as one,
@unaids
@globalfund
&
@pepfar
call for the Act to be reconsidered to ensure equitable access to health services and end AIDS by 2030.
Applications for the HIV Research Trust's 2019 scholarships are now open. The scholarships are available for physicians, nurses, scientists & health care professionals from low- & lower-middle-income countries working in
#HIV
. Applications close 12 October
“The thing that has puzzled and disturbed me the most is that I have never seen a virus in which the same pathogen, with little change, has an extraordinary range from no symptoms to death.” – Dr Anthony S. Fauci discussing the wide spectrum of COVID-19
#COVIDconf
"These new findings reaffirm our belief that there exists a proof of concept that HIV is curable." Just announced! HIV-positive man remains in HIV remission off ART for 19 months after bone marrow tranpslant. Our statement on
#HIVcure
research implications
"We understand that while technologies that address HIV are necessary - and believe me, they are very, very valued - they are not, in themselves, sufficient to change the trajectory of the epidemic without lubricating social pathways."-
@KirbyInstitute
’s Bridget Haire 🇦🇺
#IAS2023
Today at
#AIDS2018
we join 20 leading
#HIV
scientists to launch the Expert Consensus Statement on
#HIV
Criminalization. Published in
@jiasociety
, the statement lays out the science and refutes the rationale for laws that criminalize HIV transmission
Defective
#HIV
particles that persistently produce viral components despite antiretroviral therapy could be the source of the ongoing inflammation observed in individuals living with HIV, according to a new study by
@NIH
researchers.
Read + in
@aidsmap
:
A warm welcome to all our members and partners joining us at the first official day of the 23rd International
@AIDS_conference
! We look forward to accelerating the global response to HIV together.
#AIDS2020Virtual
#SayZero
!
@WHO
's announcement at
#IAS2023
confirmed that Undetectable+Untransmittable=ZERO Risk.
Read
@glaad
's article on this important milestone with the potential to transform the lives of millions of people living w/ or vulnerable to
#HIV
.
#UequalsU
🙋🏿♂️ Considering applying to the IAS Youth Hub Seed Grant Programme? Want advice from reviewers & successful applicants?
🌐 Join us this Tuesday, 16 January at 14:00 CET for a free webinar: "Granting success: How to craft compelling funding applications"!
A new study published in
@ScienceTM
may hold the key to a potential
#HIV
cure. Focused on people living with both HIV and cancer, the study found that pembrolizumab, a cancer drug, can flush HIV from hiding spot in immune cells.
There is no evidence that
#COVID19
vaccines have more side-effects in people living with
#HIV
who are on effective antiretroviral (ARV) therapy than people with no underlying health conditions. Read more:
#LanguageMatters
! People living with or vulnerable to
#HIV
experience stigma & discrimination, which can be perpetuated by one's choice of words.
@TheLancetHIV
is adopting people-first language for its HIV-related content.
Read about this development:
"The Archbishop was a fervent ally of the International AIDS Society. Tutu cared that people living with and impacted by
#HIV
and TB everywhere would receive the best care, compassion and treatments regardless of origin and background." - IAS Past President
@LindaGailBekker
Born with
#HIV
, IAS Member
@D_Moraa
found out her status only when she was 13. Stigma and treatment fatigue made her keep it a secret. Doreen is now a social media influencer in
#Kenya
🇰🇪.
Read Dora's
#IASONEVOICE
"Born with HIV: My beautiful story."
"If you protect your own country, without protecting the world, the
#COVID19
pandemic will go on and on."
@NIAID
Director Anthony Fauci discussing the importance of global equitable access to vaccines at the IAS COVID-19 Conference: Prevention media roundtable
#COVID19
.
📣
@WHO
put out a clear message at
#IAS2023
that people living with
#HIV
have “zero risk” of transmitting HIV if they adhere to prescribed treatment.
✅ Find out more about this update & help spread the word far & wide using
#SayZero
on social media!
📝 Your words matter.
🌍 Leverage language that promotes inclusivity, dialogue and equality.
👥 Learn more and join us in putting people first!
#HIVLanguageMatters
#HIV
#LanguageMatters
Today, on
#HIVVaccineAwarenessDay
, we are launching
#HIVunmuted
, our podcast series marking 40 years since AIDS was first reported. Listen to Episode 1 with host
@FemiOke
and Dr Anthony Fauci on the early days of AIDS and the quest for a vaccine
#HVAD
“Three decades into the epidemic, it remains clear: HIV and AIDS doesn't discriminate; People do.” We’re proud to share the IAS Annual Letter dedicated to addressing the underlying core of HIV: stigma.
#HeartofStigma
This
#newyear
, let's commit to
#PutPeopleFirst
in the language we use.
This is because words have power: they bestow or remove dignity, build or break stigma, and divide or unite the
#HIV
response.
#HIVLanguageMatters
Find out more 👉
Lockdowns can't last forever. In the spirit of
#ubuntu
, "I am, because you are", we can pivot from anxiety to self-efficacy and take collective action to live with the virus while being responsible for ourselves and others. CAPRISA's Prof Salim Abdool Karim speaking at
#COVIDconf
“The
#HIV
movement teaches us that successful pandemic responses require respect for human rights and gender equality, a commitment to leave no one behind, community-led service delivery and innovation.”
@antonioguterres
Secretary-General of the
@UN
wrapping up the
#COVIDconf
.
🧪A Phase 1 trial of an
#HIV
preventive vaccine has started in the US and South Africa.
This trial aims to assess the vaccine's safety and its ability to trigger an HIV-specific immune response.
Find out more about the study from
@HIVGov
:
Exciting news in the search for an
#HIV
vaccine! The African-led & coordinated
@PrEPVacc
clinical trial is entering stage 3 & could mark the start of a new era of vaccine development.
Read
@CNN
's coverage, incl. insights by IAS President
@ProfSharonLewin
!
👏 Newly elected IAS Governing Council members assumed their roles at
#AIDS2024
. We're thrilled to have familiar and new faces joining us for the 2022-2024 term!
Learn more about all our Governing Council members now!
A new
#HIV
clinical trial shows promising results using a "strategy involving an adeno-associated viral vector-based gene delivery system that instructs cells to pump out antibodies that block HIV." via
@sciencedaily
The first long-acting injectable
#HIV
treatment in Europe has received marketing authorization by the European Commission. The long-acting regime could potentially alleviate the need for daily therapy for those living with HIV
We are excited to announce a selection of the featured speakers taking part in
#IAS2023
!
Meet the speakers now & join us in
#Brisbane
,
#Australia
, or virtually from 23 to 26 July to hear leading experts discuss the latest in cutting-edge
#HIV
research!